Evidence map›Paper›PMID 31605656›Full record

ArticleJournal of diabetes investigation2020

Associations of anemia and hemoglobin with hemoglobin A1c among non-diabetic workers in Japan.

Nobuaki Sakamoto, Huanhuan Hu, Akiko Nanri, Tetsuya Mizoue, Masafumi Eguchi, Takeshi Kochi, Tohru Nakagawa, Toru Honda, Shuichiro Yamamoto, Takayuki Ogasawara and 16 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 14 institutions in 1 country.

Nobuaki SakamotoHealth Design Inc., Tokyo, Japan.
Huanhuan HuDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8558-2895
Akiko NanriDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7487-8778
Tetsuya MizoueDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Masafumi EguchiFurukawa Electric Co., Ltd., Tokyo, Japan.
Takeshi KochiFurukawa Electric Co., Ltd., Tokyo, Japan.
Tohru NakagawaHitachi, Ltd., Ibaraki, Japan.
Toru HondaHitachi, Ltd., Ibaraki, Japan.
Shuichiro YamamotoHitachi, Ltd., Ibaraki, Japan.
Takayuki OgasawaraMitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.
Naoko SasakiMitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.
Akiko NishiharaAzbil Corporation, Tokyo, Japan.
Teppei ImaiAzbil Corporation, Tokyo, Japan.
Toshiaki MiyamotoNippon Steel Corporation Kimitsu Works, Chiba, Japan.
Makoto YamamotoYamaha Corporation, Shizuoka, Japan.
Hiroko OkazakiMitsui Chemicals, Inc., Tokyo, Japan.
Kentaro TomitaMitsubishi Plastics, Inc., Tokyo, Japan.
Akihiko UeharaSeijinkai Shizunai Hospital, Hokkaido, Japan.
Ai HoriDepartment of Global Public Health, University of Tsukuba, Ibaraki, Japan.
Makiko ShimizuMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.
Taizo MurakamiMizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.
Keisuke KuwaharaDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Ami FukunagaDepartment of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Isamu KabeFurukawa Electric Co., Ltd., Tokyo, Japan.
Tomofumi SoneNational Institute of Public Health, Saitama, Japan.
Seitaro DohiMitsui Chemicals, Inc., Tokyo, Japan.
National Center for Global Health and Medicine · JPFurukawa Electric (Japan) · JPHitachi (Japan) · JPAzbil (Japan) · JPKeihin (Japan) · JPMitsubishi Motors (Japan) · JPMitsui Chemicals (Japan) · JPFukuoka Women's University · JPMitsubishi Plastics (Japan) · JPNational Institute of Public Health · JPNippon Steel (Japan) · JPUniversity of Tokyo Health Sciences · JPUniversity of Tsukuba · JPYamaha (Japan) · JP

Funding

Industrial Health Foundation, Industrial Disease Clinical Research Grants 140202-01, 150903-01, 170301-01Japan Society for the Promotion of Science KAKENHI 16H05251National Center for Global Health and Medicine 28-Shi-1206
6 · The paper itself

Abstract

AIMS/

introductionWe examined the association between hemoglobin A1c (HbA1c) and anemia, which was categorized into three groups according to mean corpuscular volume (MCV), as well as the association between hemoglobin in the non-anemic range and HbA1c. MATERIALS AND

methodsWe used the 2016 health checkup data from 36,422 workers without diabetes. Anemic people were divided into three groups based on MCV: <80, 80-90 and >90 fL. Non-anemic people were divided into four groups based on their hemoglobin levels. We carried out multiple linear regression models to estimate the means and 95% confidence intervals (CIs) of HbA1c.

resultsFor men, 0.2% had anemia with MCV <80 fL, 0.5% had anemia with MCV 80-90 fL, 0.9% had anemia with MCV >90 fL and 98.4% had no anemia. For women, the corresponding values were 6.1, 6.4, 2.8 and 84.7%, respectively. The adjusted mean HbA1c (%) values for men with anemia with MCV <80, 80-90 and >90 fL were 5.67 (95% CI 5.60-5.74), 5.58 (95% CI 5.54-5.62) and 5.41 (95% CI 5.37-5.44), respectively. Among men without anemia, HbA1c (%) increased from 5.36 (95% CI 5.34-5.39) in those with hemoglobin ≥17.5 mg/dL to 5.45 (95% CI 5.45-5.46) in those with hemoglobin 13.0 to <14.5 mg/dL (P for trend <0.001). The HbA1c values were higher in men with anemia with MCV <80 fL or MCV 80-90 fL, but lower in men with MCV >90 fL, compared with non-anemic men with hemoglobin 13.0 to <14.5 mg/dL (All P < 0.001). Similar findings were observed in women.

conclusionsWe observed elevated HbA1c among anemic people with MCV <80 fL or MCV 80-90 fL, and decreased HbA1c among anemic people with MCV >90 fL, suggesting that different types of anemia might influence HbA1c differently. In addition, non-anemic people with lower hemoglobin levels had higher HbA1c levels, suggesting that hemoglobin levels are in need of consideration when interpreting HbA1c values among non-anemic people.

Indexed as

AdultAnemiaAsian PeopleErythrocyte IndicesFemaleGlycated HemoglobinHemoglobinsHumansJapanMaleMiddle AgedGlycated Hemoglobinhemoglobin A1c protein, humanHemoglobinsAnemiaHemoglobinHemoglobin A1c

Identifiers

PMID31605656
PMCPMC7232301
OpenAlexW2979885179

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.